# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Piper Sandler analyst Jessica Tassan maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target f...
Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and se...
Canaccord Genuity analyst Richard Close maintains Health Catalyst (NASDAQ:HCAT) with a Buy and maintains $11 price target.
Wells Fargo analyst Stan Berenshteyn maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target f...
Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03...